These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10411186)

  • 21. Secondary prevention in coronary heart disease. Effects of statins have been in addition to those of aspirin and beta blockers.
    Morrell J
    BMJ; 1999 May; 318(7195):1419-20. PubMed ID: 10334767
    [No Abstract]   [Full Text] [Related]  

  • 22. [Helsinki Heart Study].
    Sekiya M; Ishibashi S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():404-9. PubMed ID: 11347103
    [No Abstract]   [Full Text] [Related]  

  • 23. Secondary prevention of coronary heart disease in clinical practice: special considerations for intensified lifestyle modification.
    Martínez-Rubio A
    Eur J Clin Invest; 1999 May; 29(5):365-8. PubMed ID: 10354191
    [No Abstract]   [Full Text] [Related]  

  • 24. After the meta-analyses: a commentary on treatment of dyslipidaemia in the primary prevention of coronary heart disease.
    Silberberg JS
    Aust N Z J Med; 1994 Dec; 24(6):717-21. PubMed ID: 7717926
    [No Abstract]   [Full Text] [Related]  

  • 25. [Life-long life style changes. A model of self care in coronary disease focused on behavior].
    Lisspers J; Ohman A
    Lakartidningen; 1996 Apr; 93(15):1453-8. PubMed ID: 8667737
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hyperlipidemia in the elderly].
    Kawano M
    Nihon Rinsho; 2002 May; 60(5):1017-23. PubMed ID: 12029980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The triglyceride-high-density lipoprotein axis: an important target of therapy?
    Szapary PO; Rader DJ
    Am Heart J; 2004 Aug; 148(2):211-21. PubMed ID: 15308990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary prevention of coronary disease with lipid-lowering drugs.
    Lancet; 1989 Mar; 1(8636):473-4. PubMed ID: 2563844
    [No Abstract]   [Full Text] [Related]  

  • 29. Ask the doctors. I am a 62-year-old female with no chronic health problems, but I am about 10 pounds overweight. My new doctor wants to put me on a statin immediately. My total cholesterol is 187: my LDL is 129, my HDL is 47, and my triglycerides are 55. He is concerned because my father died of a heart attack from coronary artery disease. The doctor wants my HDL to be above 60 and my LDL to be below 100. Could this result be achieved by weight loss, dietary changes, and exercise alone? If not, which statin would you recommend?
    Lee T; Lee R
    Harv Heart Lett; 2012 Aug; 22(12):2. PubMed ID: 23025019
    [No Abstract]   [Full Text] [Related]  

  • 30. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]].
    Tomiyama H; Doba N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101
    [No Abstract]   [Full Text] [Related]  

  • 31. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Take control of triglycerides. Research shows that at least one-third of Americans have high triglycerides, but medication and lifestyle changes may help you protect your heart.
    Heart Advis; 2009 Jun; 12(6):4. PubMed ID: 19653370
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of hypercholesterolemia in women: equality, effectiveness, and extrapolation of evidence.
    Pearson TA; Myerson M
    JAMA; 1997 Apr 23-30; 277(16):1320-1. PubMed ID: 9109473
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 35. Secondary prevention in coronary heart disease. Cost effectiveness of treatment must be borne in mind.
    Ferner RE
    BMJ; 1998 Dec; 317(7172):1592. PubMed ID: 9836677
    [No Abstract]   [Full Text] [Related]  

  • 36. Beyond low-density lipoprotein cholesterol: why, who and when.
    Chang CN; How CH; Tavintharan S
    Singapore Med J; 2012 Sep; 53(9):566-8; quiz 569. PubMed ID: 23023895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing serum cholesterol. Confusion remains over whom to treat.
    Weetman DF
    BMJ; 1993 Jul; 307(6896):125. PubMed ID: 8343716
    [No Abstract]   [Full Text] [Related]  

  • 38. Coronary heart disease. New guidelines for prevention.
    Harv Womens Health Watch; 1999 Aug; 6(12):2-3. PubMed ID: 10402323
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lifestyle-related diseases: Dyslipidemia].
    Moriyama T
    Nihon Jinzo Gakkai Shi; 2005; 47(1):8-16. PubMed ID: 15754758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.